【正文】 CHRANE 協(xié)作網(wǎng)規(guī)定，不接受可能對評價結(jié)果造成利益導(dǎo)向的單方面資金贊助。s Code of Conduct for Avoiding Potential Financial Conflicts of Interest (see appendix 2b): ? Receipt of benefits from any source of sponsored research must be acknowledged and conflicts of interest must be disclosed in CDSR and other publications that emanate from the Collaboration. ? If a proposal raises a question of serious conflict of interest, this should be forwarded to the local Cochrane Centre for review (and the Steering Group notified accordingly). ? It is not mandatory to send funding proposals to the local Cochrane Centre or Steering Group prior to accepting them. However, this would be desirable in the cases of restricted donations, or any donation that appears to conflict with the general principle noted above. 以下推薦政策來自于合作條文以避免出現(xiàn)潛在的利益沖突（見附錄 2b） . 通過任何研究所 獲的的經(jīng)濟利益必須是公開的，而且利益沖突必需在 CDSR 或者合作組織發(fā)布的出版物中披露。 不強制要求向地方中心或者管理層提供資金建議，但鼓勵提供適當(dāng)?shù)木栀?，特別是與一般原則有關(guān)的捐贈。 如果研究計劃引發(fā)嚴(yán)重利益沖突，應(yīng)提交當(dāng)?shù)?COCHRANE 中心考察 （并相應(yīng)的知會指導(dǎo)委員會） 不強制要求在接受贊助前將被贊助計劃送交當(dāng)?shù)?COCHRANE 中心或指導(dǎo)委員會。） Conflict of interest statements in reviews 綜述中提及的利益沖突（利益沖突聲明） Under the heading 39。 reviewers should report any conflict of interest capable of influencing their judgements, including personal, political, academic and other possible conflicts, as well as financial conflicts. It is impossible to abolish conflict of interest, since the only person who does not have some vested interest in a subject is somebody who knows nothing about it (Smith 1994). Financial conflicts of interest cause the most concern, can and should be avoided, but must be reported if there are any. Any secondary interest (such as personal conflicts) that might unduly influence judgements made in a review (concerning, for example, the inclusion or exclusion of studies, assessments of the validity of included studies or the interpretation of results) should be reported. 評論者可以報道一些影響他們判斷的利益沖突，包括個人的、政 治的、學(xué)術(shù)的和其他可能的沖突，也可以是經(jīng)濟上的沖突。經(jīng)濟利益上的沖突應(yīng)該引起更大的關(guān)注，應(yīng)該而且必須避免，但是如果出現(xiàn)應(yīng)隨時提出。 （在“利益沖突”標(biāo)題下，評價者應(yīng)報告任何可能影響他們判斷的利益沖突，包括來自個人、政 治、學(xué)術(shù)和其他可能的沖突以及經(jīng)濟沖突。（ Smith 1994) 經(jīng)濟利益沖突最受 人關(guān)注，是能夠并應(yīng)該避免的，一旦存在，則必須在報告中予以透露。） Disclosing a conflict of interest does not necessarily reduce the worth of a review and it does not imply dishonesty. However, conflicts of interest can influence judgements in subtle ways. Reviewers should let the editors of their Collaborative Review Group know of potential conflicts even when they are confident that their judgements were not or will not be influenced. Editors may decide that disclosure is not warranted or they may decide that readers should know about such a conflict of interest so that they can make up their own minds about how important it is. Decisions about whether or not to publish such information should be made jointly by reviewers and editors. 披露利益沖突并沒有降低綜述的價值，并不反映綜述的不真實性。即使他們自信他們的判斷力并沒有受到影響，評論者也應(yīng)該讓編輯人員了解潛在的沖突。 （披露利益沖突并不一定會降低評價的價值，也并不意味著不誠實。即使評價者堅信自己的判斷力不會受影響，也應(yīng)讓 CRG 的編輯們知曉潛在的沖突。但最后是否發(fā)表該信息要由評價者和編輯共同決定。 （為保證 COCHRANE 系統(tǒng)評價的公正性和完整性，除應(yīng)暴光利益沖突外，所有的評價者還必須按規(guī)定格式簽署相關(guān)聲明，并同意 COCHRANE 協(xié)作網(wǎng)發(fā)表他們的系統(tǒng)評價。這種合作中的關(guān)鍵因素是： cochrane 評論者必須不受制于其合作雜志，為自由之身。 （ COCHRANE 評價者可能希望尋求有同行審稿的醫(yī)學(xué)雜志共同出版 COCHRANE 系統(tǒng)評價，尤其是對共同發(fā)表 COCHRANE 系統(tǒng) 評價表現(xiàn)了極高熱情的雜志。為了保證該條件的實施， COCHRANE 評價者授予 COCHRANE 協(xié)作網(wǎng)全球許可證，不與任何雜志或其他出版商簽署獨家版權(quán)所有的協(xié)定。） Reviewers are strongly discouraged from publishing Cochrane Reviews in journals before they are ready for publication in CDSR. This applies particularly to Centre directors and editors of Review Groups. However, journals will sometimes insist that the publication of the review in CDSR should not precede publication in print. When this is the case, reviewers should submit a review for publication in the journal after agreement from their CRG editor and before publication in CDSR. Publication in print should not be subject to lengthy production times, and reviewers should not unduly delay publication of a Cochrane Review either because of delays from a journal or in order to resubmit their review to another journal. 評論者準(zhǔn)備發(fā)表在 CDSR 上時而被發(fā)表在 cochrane 綜述上，這一點使他們非常失望。這種情況下，評論者應(yīng) 該在爭得統(tǒng)一后在發(fā)表之前遞交一份在雜志上的出版原件。 （我們強烈反對評價者早于 CDSR 在雜志發(fā)表他們的系統(tǒng)評價，